Not all neurogenic bladders are the same

A proposal for a new neurogenic bladder classification system

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Neurogenic bladder (NGB) has long been defined as a clinical entity that describes a heterogeneous collection of syndromes. The common theme is a bladder disorder concomitant with a neurologic disorder. This definition does not give the clinician much information about the bladder disorder, nor how to treat it, or even what the natural history of the disorder is likely to be. It may be time for a new classification scheme to better define the bladder defect and prognosis, as well as inform treatment. We propose a classification system based on seven categories, each having a neurologic defect in a distinct anatomic location. This is termed SALE (Stratify by Anatomic Location and Etiology). In addition, the presence or absence of bowel dysfunction and autonomic dysreflexia will be reported. In the future, as more definite prognostic information can be gleaned from biomarkers, we anticipate adding urinary nerve growth factor (NGF) and urinary brain-derived neurotrophic factor (BDNF) levels to the definition. We expect the SALE system to efficiently describe a patient suffering from NGB and simultaneously inform the most appropriate treatment, follow-up regimen, and long-term prognosis.

Original languageEnglish (US)
Pages (from-to)12-21
Number of pages10
JournalTranslational Andrology and Urology
Volume5
Issue number1
DOIs
StatePublished - 2016

Fingerprint

Neurogenic Urinary Bladder
Urinary Bladder
Autonomic Dysreflexia
Brain-Derived Neurotrophic Factor
Nerve Growth Factor
Nervous System Diseases
Natural History
Nervous System
Biomarkers
Therapeutics

Keywords

  • Autonomic nervous system (ANS)
  • Brain-derived neurotrophic factor (BDNF)
  • Nerve growth factor (NGF)
  • Urinary bladder; neurogenic
  • Urodynamics

ASJC Scopus subject areas

  • Reproductive Medicine
  • Urology

Cite this

@article{2e41c63aec254fc6a2bfe6772c08008a,
title = "Not all neurogenic bladders are the same: A proposal for a new neurogenic bladder classification system",
abstract = "Neurogenic bladder (NGB) has long been defined as a clinical entity that describes a heterogeneous collection of syndromes. The common theme is a bladder disorder concomitant with a neurologic disorder. This definition does not give the clinician much information about the bladder disorder, nor how to treat it, or even what the natural history of the disorder is likely to be. It may be time for a new classification scheme to better define the bladder defect and prognosis, as well as inform treatment. We propose a classification system based on seven categories, each having a neurologic defect in a distinct anatomic location. This is termed SALE (Stratify by Anatomic Location and Etiology). In addition, the presence or absence of bowel dysfunction and autonomic dysreflexia will be reported. In the future, as more definite prognostic information can be gleaned from biomarkers, we anticipate adding urinary nerve growth factor (NGF) and urinary brain-derived neurotrophic factor (BDNF) levels to the definition. We expect the SALE system to efficiently describe a patient suffering from NGB and simultaneously inform the most appropriate treatment, follow-up regimen, and long-term prognosis.",
keywords = "Autonomic nervous system (ANS), Brain-derived neurotrophic factor (BDNF), Nerve growth factor (NGF), Urinary bladder; neurogenic, Urodynamics",
author = "Charles Powell",
year = "2016",
doi = "10.3978/j.issn.2223-4683.2016.01.02",
language = "English (US)",
volume = "5",
pages = "12--21",
journal = "Translational Andrology and Urology",
issn = "2223-4683",
publisher = "AME Publishing Company",
number = "1",

}

TY - JOUR

T1 - Not all neurogenic bladders are the same

T2 - A proposal for a new neurogenic bladder classification system

AU - Powell, Charles

PY - 2016

Y1 - 2016

N2 - Neurogenic bladder (NGB) has long been defined as a clinical entity that describes a heterogeneous collection of syndromes. The common theme is a bladder disorder concomitant with a neurologic disorder. This definition does not give the clinician much information about the bladder disorder, nor how to treat it, or even what the natural history of the disorder is likely to be. It may be time for a new classification scheme to better define the bladder defect and prognosis, as well as inform treatment. We propose a classification system based on seven categories, each having a neurologic defect in a distinct anatomic location. This is termed SALE (Stratify by Anatomic Location and Etiology). In addition, the presence or absence of bowel dysfunction and autonomic dysreflexia will be reported. In the future, as more definite prognostic information can be gleaned from biomarkers, we anticipate adding urinary nerve growth factor (NGF) and urinary brain-derived neurotrophic factor (BDNF) levels to the definition. We expect the SALE system to efficiently describe a patient suffering from NGB and simultaneously inform the most appropriate treatment, follow-up regimen, and long-term prognosis.

AB - Neurogenic bladder (NGB) has long been defined as a clinical entity that describes a heterogeneous collection of syndromes. The common theme is a bladder disorder concomitant with a neurologic disorder. This definition does not give the clinician much information about the bladder disorder, nor how to treat it, or even what the natural history of the disorder is likely to be. It may be time for a new classification scheme to better define the bladder defect and prognosis, as well as inform treatment. We propose a classification system based on seven categories, each having a neurologic defect in a distinct anatomic location. This is termed SALE (Stratify by Anatomic Location and Etiology). In addition, the presence or absence of bowel dysfunction and autonomic dysreflexia will be reported. In the future, as more definite prognostic information can be gleaned from biomarkers, we anticipate adding urinary nerve growth factor (NGF) and urinary brain-derived neurotrophic factor (BDNF) levels to the definition. We expect the SALE system to efficiently describe a patient suffering from NGB and simultaneously inform the most appropriate treatment, follow-up regimen, and long-term prognosis.

KW - Autonomic nervous system (ANS)

KW - Brain-derived neurotrophic factor (BDNF)

KW - Nerve growth factor (NGF)

KW - Urinary bladder; neurogenic

KW - Urodynamics

UR - http://www.scopus.com/inward/record.url?scp=84957682349&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957682349&partnerID=8YFLogxK

U2 - 10.3978/j.issn.2223-4683.2016.01.02

DO - 10.3978/j.issn.2223-4683.2016.01.02

M3 - Article

VL - 5

SP - 12

EP - 21

JO - Translational Andrology and Urology

JF - Translational Andrology and Urology

SN - 2223-4683

IS - 1

ER -